http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2299051-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0de3c2a3b6a654048399cc756869a0f3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65835f8779f2b59f6aaa14e531337527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eee976623e41cddebab640c5b79260d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb27c74b52f1b367777b6d963e14656a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dcfc38489eba6d4ead6a954bbe6943f
publicationDate 2007-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2299051-C1
titleOfInvention Method for intraoperationally stopping epiretinal hemorrhages and removing epiretinal blood
abstract FIELD: medicine. n SUBSTANCE: method involves introducing hemostatic sponge via sclerostoma into vitreous cavity filled with polyorganophosphoroous compound. Sponge is 1.5 x 2 mm large. The sponge is pressed to epiretinal hemorrhage place on the retina for a time needed to achieve complete hemostasis. Then, epiretinal hemorrhage places are dried above the retina. n EFFECT: enhanced effectiveness in removing blood without polyorganophosphoroous compound loss taking place; accelerated operation; reduced risk of secondary hemorrhages and neovascular proliferative membrane recurrence.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611920-C1
priorityDate 2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483

Total number of triples: 17.